The drugs don’t work: stopping the spread of the superbugs

Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical companies are fighting back. Sarah Moore reports.

942-bug-634

Imagine dying of an infected cut on your finger. Or being told that a hip procedure or liver transplant could end up killing you. This may sound like a medical disaster film, but it could well happen fairly soon. Bacteria are becoming increasingly resistant to the antibiotics used to cure common ailments and illnesses, or to prevent infection during surgery.

If these resistant "superbugs" prevail, antibiotics will be ineffective and "modern medicine will be lost", says Dame Sally Davies, the chief medical officer for England. As antibiotics stop working, a growing list of infections – notably pneumonia, tuberculosis, blood poisoning, gonorrhoea, and food-borne diseases – are becoming harder, and sometimes impossible, to treat, says the World Health Organisation (WHO). What would once have been easily treated afflictions could once again prove fatal, while surgery could be vastly more dangerous. "Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill."

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Explore More

Sarah is MoneyWeek's investment editor. She graduated from the University of Southampton with a BA in English and History, before going on to complete a graduate diploma in law at the College of Law in Guildford. She joined MoneyWeek in 2014 and writes on funds, personal finance, pensions and property.